NEW YORK, Nov 16 (Reuters) - U.S. Treasury yields rose on Monday and the yield curve steepened as news of another promising coronavirus vaccine boosted optimism that the economy may be closer to returning to normal, but that was tempered by a likely slow rollout.
Moderna Inc's experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company said on Monday, becoming the second U.S. drugmaker in as many weeks to report results that far exceeded expectations.
Benchmark 10-year yields rose 1.5 basis points to 0.908%.
The yields reached an eight-month high of 0.975% last Monday, ahead of new supply of three-year, 10-year and 30-year debt as part of the Treasury's quarterly refunding.
The yield curve between two-year and 10-year notes steepened one basis point to 73 basis points.
The Federal Reserve Chairman, Jerome Powell will speak on Tuesday at a Bay Area Council Business Hall of Fame awards event.
Read more from the original article:
免責事項：本記事で述べられている見解は著者の見解のみであり、Followmeの公式見解を反映するものではありません。Followmeは、提供された情報の正確性、完全性、信頼性について一切責任を負いません。また、書面で明示的に記載されている場合を除き、本記事の内容に基づいて行われたいかなる行動についても責任を負いません。
古いコメントはありません。ソファをつかむ最初のものになりましょう。